In conclusion, this comparative cross-sectional study demonstrates that the highest expression levels of the cancer stem cell marker CD44 and cytoplasmic VDR are significantly associated with aggressive histological types of EOT, particularly in patients with HGSC in FIGO stages III or IV. This evidence concerns the gene CD44 and cancer.